• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Unexpectedly High Coexistence Rate of /Invasive Carcinoma In Phyllodes Tumors. 10-Year Retrospective and Review Study.叶状肿瘤中浸润性癌的意外高共存率。一项10年的回顾性研究与文献综述
Eur J Breast Health. 2022 Oct 1;18(4):343-352. doi: 10.4274/ejbh.galenos.2022.2022-6-2. eCollection 2022 Oct.
2
Surgical treatment of phyllodes tumors of the breast: retrospective review of 172 cases.乳腺叶状肿瘤的外科治疗:172例回顾性分析
J Surg Oncol. 2005 Sep 1;91(3):185-94. doi: 10.1002/jso.20334.
3
Local Recurrence of Benign, Borderline, and Malignant Phyllodes Tumors of the Breast: A Systematic Review and Meta-analysis.乳腺良性、交界性和恶性叶状肿瘤局部复发:系统评价和荟萃分析。
Ann Surg Oncol. 2019 May;26(5):1263-1275. doi: 10.1245/s10434-018-07134-5. Epub 2019 Jan 7.
4
Prognostic factors in phyllodes tumours of the breast: retrospective study on 166 consecutive cases.乳腺叶状肿瘤的预后因素:166 例连续病例的回顾性研究。
ESMO Open. 2020 Oct;5(5):e000843. doi: 10.1136/esmoopen-2020-000843.
5
Phyllodes Tumor of the Breast: A Clinicopathological Evaluation of 55 Cases.乳腺叶状肿瘤:55例临床病理分析
Eur J Breast Health. 2019 Oct 3;16(1):32-38. doi: 10.5152/ejbh.2019.4709. eCollection 2020 Jan.
6
Clinicopathological Parameters Predicting Malignancy in Phyllodes Tumor of the Breast.预测乳腺叶状肿瘤恶性程度的临床病理参数
Cureus. 2023 Sep 28;15(9):e46168. doi: 10.7759/cureus.46168. eCollection 2023 Sep.
7
Stromal cells in phyllodes tumors of the breast are enriched for EZH2 and stem cell marker expression.乳腺叶状肿瘤中的基质细胞富含EZH2和干细胞标志物表达。
Breast Cancer Res Treat. 2016 Jul;158(1):21-28. doi: 10.1007/s10549-016-3853-5. Epub 2016 Jun 11.
8
Coexistence of benign phyllodes tumor and invasive ductal cancer in the ipsilateral breast: A case report.同侧乳腺良性叶状肿瘤与浸润性导管癌并存:一例报告。
Int J Surg Case Rep. 2024 Sep;122:110162. doi: 10.1016/j.ijscr.2024.110162. Epub 2024 Aug 13.
9
Coexistence of Ductal Carcinoma Within Mammary Phyllodes Tumor: A Review of 557 Cases From a 20-year Region-wide Database in Hong Kong and Southern China.乳腺叶状肿瘤中导管癌共存:来自香港和中国南方 20 年全地区数据库的 557 例回顾。
Clin Breast Cancer. 2018 Jun;18(3):e421-e425. doi: 10.1016/j.clbc.2017.06.001. Epub 2017 Jun 17.
10
[Treatment of phyllodes tumours of the breast: evaluation of 66 cases and literature review].[乳腺叶状肿瘤的治疗:66例病例评估及文献综述]
Handchir Mikrochir Plast Chir. 2021 Apr;53(2):159-167. doi: 10.1055/a-1164-6791. Epub 2020 Aug 12.

引用本文的文献

1
Coexistence of benign phyllodes tumor and invasive ductal cancer in the ipsilateral breast: A case report.同侧乳腺良性叶状肿瘤与浸润性导管癌并存:一例报告。
Int J Surg Case Rep. 2024 Sep;122:110162. doi: 10.1016/j.ijscr.2024.110162. Epub 2024 Aug 13.
2
Management of Concurrent Malignant Phyllodes Tumor and Invasive Breast Carcinoma.同时性恶性叶状肿瘤与浸润性乳腺癌的管理
Adv Radiat Oncol. 2024 Jan 26;9(5):101448. doi: 10.1016/j.adro.2024.101448. eCollection 2024 May.

本文引用的文献

1
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
2
Malignant phyllodes tumors of the breast associating malignancy of both mesenchymal and epithelial components (invasive or in situ ductal carcinoma).乳腺恶性叶状肿瘤,伴间质和上皮成分的恶性肿瘤(浸润性或原位导管癌)。
Rom J Morphol Embryol. 2020;61(1):129-135. doi: 10.47162/RJME.61.1.14.
3
Phyllodes Tumor of the Breast: A Clinicopathological Evaluation of 55 Cases.乳腺叶状肿瘤:55例临床病理分析
Eur J Breast Health. 2019 Oct 3;16(1):32-38. doi: 10.5152/ejbh.2019.4709. eCollection 2020 Jan.
4
Neuroendocrine carcinoma of the breast arising in malignant phyllodes tumor.起源于恶性叶状肿瘤的乳腺神经内分泌癌。
Breast J. 2020 Feb;26(2):276-277. doi: 10.1111/tbj.13551. Epub 2019 Sep 8.
5
NCCN Guidelines Updates: Breast Cancer.NCCN 指南更新:乳腺癌。
J Natl Compr Canc Netw. 2019 May 1;17(5.5):552-555. doi: 10.6004/jnccn.2019.5006.
6
Synchronous malignant phyllodes tumour and invasive lobular carcinoma-case report and review.同步性恶性叶状肿瘤和浸润性小叶癌——病例报告及文献复习
J Surg Case Rep. 2018 Oct 8;2018(10):rjy258. doi: 10.1093/jscr/rjy258. eCollection 2018 Oct.
7
Is excision biopsy of fibroadenomas based solely on size criteria warranted?基于大小标准对纤维腺瘤进行切除术活检是否合理?
Breast J. 2018 Nov;24(6):981-985. doi: 10.1111/tbj.13069. Epub 2018 May 25.
8
Malignant Epithelial Transformation in Phyllodes Tumor: A Population-Based Case Series.叶状肿瘤中的恶性上皮化生:一项基于人群的病例系列研究。
Cureus. 2017 Nov 3;9(11):e1815. doi: 10.7759/cureus.1815.
9
Coexistence of Ductal Carcinoma Within Mammary Phyllodes Tumor: A Review of 557 Cases From a 20-year Region-wide Database in Hong Kong and Southern China.乳腺叶状肿瘤中导管癌共存:来自香港和中国南方 20 年全地区数据库的 557 例回顾。
Clin Breast Cancer. 2018 Jun;18(3):e421-e425. doi: 10.1016/j.clbc.2017.06.001. Epub 2017 Jun 17.
10
Synchronous Malignant Phyllodes Tumor with Skin Ulceration and Invasive Carcinoma as Collision Tumor.伴有皮肤溃疡的同步性恶性叶状肿瘤及作为碰撞瘤的浸润性癌
Indian J Med Paediatr Oncol. 2017 Jan-Mar;38(1):78-80. doi: 10.4103/0971-5851.203499.

叶状肿瘤中浸润性癌的意外高共存率。一项10年的回顾性研究与文献综述

Unexpectedly High Coexistence Rate of /Invasive Carcinoma In Phyllodes Tumors. 10-Year Retrospective and Review Study.

作者信息

Gemci Öykü Dila, Altınay Serdar, İlbar Tartar Rümeysa, Ferahman Sina

机构信息

Department of Pathology, Bakırköy Dr. Sadi Konuk Training and Research Hospital, University of Health Sciences, İstanbul, Turkey.

Department of Molecular Oncology, Institute of Health Sciences, University of Health Sciences, İstanbul, Turkey.

出版信息

Eur J Breast Health. 2022 Oct 1;18(4):343-352. doi: 10.4274/ejbh.galenos.2022.2022-6-2. eCollection 2022 Oct.

DOI:10.4274/ejbh.galenos.2022.2022-6-2
PMID:36248757
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9521284/
Abstract

OBJECTIVE

Phyllodes tumors (PTs) are a rare group of breast tumors. Most malignant transformations are carcinomas that are extremely rare and are limited to individual cases in the literature. The presence of /invasive carcinomas is important as this may alter clinical judgment and management. In this study, we aimed to determine the association of /invasive carcinomas among PTs.

MATERIALS AND METHODS

This retrospectively designed study included cases diagnosed with PTs between 2011 and 2020 in the pathology department of a tertiary level hospital. Tumors were grouped into benign, borderline and malignant, according to stromal overgrowth, stromal atypia, stromal cellularity and mitotic activity. In addition, age, location, type of operation, tumor diameter, and surgical margin information were recorded. and/or invasive carcinoma foci accompanying the PTs were assessed.

RESULTS

A total of 29 patients diagnosed with PTs were identified, among whom 14 (48.2%) had benign PTs, 10 (34.4%) had borderline PTs, and 5 (17.2%) had malignant PTs. Of the patients with PTs, 3 (10.3%) had coexistent invasive carcinoma and 1 (3.4%) had carcinoma . In this cohort the incidence of coexistence of PT and carcinoma was 4/29 (13.7%), which is much higher than previously reported (1.1% and 6%). The incidence of carcinoma was 2/5 (40%) in malignant PT patients and 2/10 (20%) in borderline PT patients. The coexistence of malignant PTs and carcinoma was significantly higher than those of benign and borderline PTs (<0.05).

CONCLUSION

The multidisciplinary team dealing with breast diseases has a great responsibility in both diagnosis and treatment. We anticipate that these rates will increase with an increase in the awareness and importance of this coexistence of carcinoma and PTs.

摘要

目的

叶状肿瘤(PTs)是一组罕见的乳腺肿瘤。大多数恶性转化为癌,极为罕见,在文献中仅限于个别病例。浸润性癌的存在很重要,因为这可能会改变临床判断和治疗方案。在本研究中,我们旨在确定PTs中浸润性癌之间的关联。

材料与方法

本项回顾性研究纳入了2011年至2020年在一家三级医院病理科诊断为PTs的病例。根据间质过度生长、间质异型性、间质细胞密度和有丝分裂活性,将肿瘤分为良性、交界性和恶性。此外,记录年龄、位置、手术类型、肿瘤直径和手术切缘信息。对PTs伴有的和/或浸润性癌灶进行评估。

结果

共确定29例诊断为PTs的患者,其中14例(48.2%)为良性PTs,10例(34.4%)为交界性PTs,5例(17.2%)为恶性PTs。在PTs患者中,3例(10.3%)并存浸润性癌,1例(3.4%)有癌。在该队列中,PT与癌并存的发生率为4/29(13.7%),远高于先前报道的(1.1%和6%)。恶性PT患者中癌的发生率为2/5(40%),交界性PT患者中为2/10(20%)。恶性PTs与癌并存的情况显著高于良性和交界性PTs(<0.05)。

结论

处理乳腺疾病的多学科团队在诊断和治疗方面都负有重大责任。我们预计,随着对癌与PTs并存情况的认识提高及其重要性的增加,这些发生率将会上升。